Navigation Links
Precedent Revision Hip Stem - HA Coated

ProductsPrecedent Revision Hip Stem - HA Coated
Company Zimmer, Inc.
Item Precedent Revision Hip Stem - HA Coated
Features Hydroxyapatite coating creates favorable environment for proximal fixation. Distal fixation avoids further proximal degeneration and ensures stability. Titanium alloy also helps avoid further proximal degeneration. Long stems are tapered to address the natural curve of the thigh bone.
Description The Precedent establishes a new generation of revision hip stems.
Info Zimmer, Inc.
Customer Service: (800) 613-6131
Web site: http://www.zimmer.com

Related medicine products :

1. Precedent Revision Hip Stem - Non coated
2. Duracon Total Stabilizer Revision System
3. Scorpio TS Single Axis Revision Knee System
4. Advance Revision Knee System
5. Natural-Knee Revision system
6. AGC Revision knee
7. Alloclassic Revision Hip
8. The Natural-Hip Family - Revision/Trauma Nonporous CoCr
9. The Natural-Hip Family - Revision/Trauma CoCr Revision
10. The Natural-Hip Family - Revision/Trauma Calcar
11. SL Revision
BD Visitec Micro Tip Cannulas
BD Visitec Membrane Dissectors
BD Pocket Scleral Blades and Knives
BD Visitec Subretinal Fluid Instruments
Medicine Products:
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
...eek March,10 - 17 unites MS organizations and all ...s nationwide in an effort to shine a spotlight on ... disease where someone is,newly diagnosed each hou...erosis Society invites people across the,county to...
...al Treatments for Children Suffering,Facial Deform...,worldwide children,s medical charity, today annou...organization as part of a ,sharing smiles, campaig...t partnered with Operation Smile to commemorate it...
...008 Hib meningitis has been virtually eliminated i...he country introduced Haemophilus influenzae type,...ndent study. , Haemophilus influenzae type b is a ...0 children,under five years of age, most of them i...
...te of Medical Research in Sydney is the first to d...-controlled asthma, regular treatment with low dos... function. , The study published in this months...ebo on asthma control in mild asthmatics. , The r...
...chers are leading the charge in adapting drug dosi... level of obesity in the Western World continues t...uce Green says researchers face the ongoing challe...hallenging role for clinicians, as the effects of ...
...dshire, March 10 IBA,Health Group company iSOFT h...ion to become its first healthcare channel partner...anagement, and user provisioning solutions., The ...ket-leading Vergence(R) SSO/context management sui...
Other Medicine News:Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 3Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 4Health News:Windows Live $500,000 Donation Commemorates Operation Smile's 25th Anniversary 2Health News:Deadly disease eliminated in children under 5 years of age in Uganda 2Health News:Deadly disease eliminated in children under 5 years of age in Uganda 3Health News:Deadly disease eliminated in children under 5 years of age in Uganda 4Health News:Treatment for mild asthma leads to improved lung function 2Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 2Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 3Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 4
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 1Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 2Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 3New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 1New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 2New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 3New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 4New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 5New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 6Elder Boom Will Be Felt Worldwide 52094 1Elder Boom Will Be Felt Worldwide 52094 2